HARP - What's Going On With Harpoon Therapeutics Stock Monday? | Benzinga
Harpoon Therapeutics Inc (NASDAQ: HARP) shares are trading higher Monday after the company announced updated data from a trial evaluating its cancer drug.
What Happened: Over the weekend, Harpoon highlighted updated interim monotherapy data from its Phase 1/2 clinical trial evaluating HPN328 in small cell lung cancer.
The company said HPN328, which is designed to recruit a patient's own immune cells to kill tumors, was generally well tolerated across all cohorts in the study and showed a confirmed response ...